ArticleJPRAS open2026
Patient-reported outcomes following chest masculinization surgery in transmasculine individuals: A prospective study.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chest masculinization surgery is a cornerstone of gender-affirming care for transmasculine individuals, with well-documented benefits on body image and quality of life. However, prospective data using validated patient-reported outcome measures (PROMs) remain limited. Methods: This prospective longitudinal study was conducted in accordance with the STROBE guidelines. Adult transmasculine patients undergoing chest masculinization surgery at Hôpital Saint-Louis (Paris, France) between April 2022 and October 2024 were invited to complete the BODY-Q questionnaire preoperatively and at 6 months postoperatively. Demographic, morphological, and surgical variables were collected. Pre-post comparisons were performed, and associations between outcomes and covariates were explored. Results: Forty-four transmasculine patients met the inclusion criteria. Mean age at surgery was 24.1 ± 5.6 years. Significant improvements were observed across all BODY-Q appearance and health-related quality-of-life domains (all Conclusions: Chest masculinization surgery was associated with marked improvements in appearance-related satisfaction and health-related quality of life at 6 months. Despite limitations related to sample size, response rate, and follow-up duration, these findings support the substantial positive impact of this procedure on patient-reported outcomes in transmasculine individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.